Jason Laine

Somerset Family Urges NHS to Fund Life-Changing Medical Cannabis 0
- CANNABIS OIL
- February 11, 2026
Emily and Spencer, parents from Nunney near Frome, say medical cannabis has transformed the life of their six-year-old daughter, Clover, who suffers from Aicardi Syndrome. Since starting treatment in 2020, her seizures have drastically reduced—from dozens daily to just a few mild ones—though the family spends £750 a month on privately sourced cannabis oil. After
READ MORE
Marijuana Legalization Edges Closer to U.S. Mainstream 0
- MEDICAL MARIJUANA
- February 6, 2026
Once criminalized nationwide by the Marihuana Tax Act of 1937, cannabis is now legal in some form across most U.S. states, with many authorizing medical use and a growing cohort permitting recreational sales. Yet federal law still classifies marijuana as a Schedule I drug under the Controlled Substances Act, creating a clash between Washington and
READ MORE

CBD Oil for Anxiety: Promise, Limits and Precautions 0
- CANNABIS OIL
- February 4, 2026
Cannabidiol (CBD) oil is emerging as a potential tool for managing anxiety, but experts caution that the evidence remains incomplete and uneven. Recent reviews suggest CBD may ease symptoms in conditions such as generalized and seasonal affective anxiety disorders, with clearer benefits at daily doses in the 300–400 milligram range, though responses vary widely between
READ MORE
Cannabis Reform in Flux: 2026 Brings Fresh Uncertainty to U.S. Weed Laws 0
- MEDICAL MARIJUANA
- January 30, 2026
As President Donald Trump’s 2025 executive order to reschedule cannabis moves forward, America’s $32 billion marijuana industry faces both promise and peril. The order directs the Attorney General to downgrade marijuana from a Schedule I to Schedule III substance—an administrative shift that could unlock major tax relief but still fall short of full legalization. Meanwhile,
READ MORE